179 related articles for article (PubMed ID: 23244735)
41. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.
Xu Q; Lin WC; Petit RS; Groves JT
Biophys J; 2011 Dec; 101(11):2731-9. PubMed ID: 22261062
[TBL] [Abstract][Full Text] [Related]
42. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
[TBL] [Abstract][Full Text] [Related]
43. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
44. In PC3 prostate cancer cells ephrin receptors crosstalk to β1-integrins to strengthen adhesion to collagen type I.
Yu M; Wang J; Muller DJ; Helenius J
Sci Rep; 2015 Feb; 5():8206. PubMed ID: 25644492
[TBL] [Abstract][Full Text] [Related]
45. The role of the Eph-ephrin signalling system in the regulation of developmental patterning.
Coulthard MG; Duffy S; Down M; Evans B; Power M; Smith F; Stylianou C; Kleikamp S; Oates A; Lackmann M; Burns GF; Boyd AW
Int J Dev Biol; 2002; 46(4):375-84. PubMed ID: 12141423
[TBL] [Abstract][Full Text] [Related]
46. Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.
Carpenter TC; Schroeder W; Stenmark KR; Schmidt EP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):40-7. PubMed ID: 21799118
[TBL] [Abstract][Full Text] [Related]
47. Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis.
Herath NI; Spanevello MD; Doecke JD; Smith FM; Pouponnot C; Boyd AW
Eur J Cancer; 2012 Mar; 48(5):753-62. PubMed ID: 21852108
[TBL] [Abstract][Full Text] [Related]
48. Expression and purification of the intact cytoplasmic domain of the human ephrin receptor A2 tyrosine kinase in Escherichia coli.
Zabell KM; Laurence JS; Kinch MS; Knapp DW; Stauffacher CV
Protein Expr Purif; 2006 May; 47(1):210-6. PubMed ID: 16426859
[TBL] [Abstract][Full Text] [Related]
49. Methylmercury alters Eph and ephrin expression during neuronal differentiation of P19 embryonal carcinoma cells.
Wilson DT; Polunas MA; Zhou R; Halladay AK; Lowndes HE; Reuhl KR
Neurotoxicology; 2005 Aug; 26(4):661-74. PubMed ID: 15990172
[TBL] [Abstract][Full Text] [Related]
50. Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.
Brantley-Sieders DM; Jiang A; Sarma K; Badu-Nkansah A; Walter DL; Shyr Y; Chen J
PLoS One; 2011; 6(9):e24426. PubMed ID: 21935409
[TBL] [Abstract][Full Text] [Related]
51. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
[TBL] [Abstract][Full Text] [Related]
52. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.
Miao H; Burnett E; Kinch M; Simon E; Wang B
Nat Cell Biol; 2000 Feb; 2(2):62-9. PubMed ID: 10655584
[TBL] [Abstract][Full Text] [Related]
53. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
[TBL] [Abstract][Full Text] [Related]
54. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
55. Eph/Ephrin signaling in injury and inflammation.
Coulthard MG; Morgan M; Woodruff TM; Arumugam TV; Taylor SM; Carpenter TC; Lackmann M; Boyd AW
Am J Pathol; 2012 Nov; 181(5):1493-503. PubMed ID: 23021982
[TBL] [Abstract][Full Text] [Related]
56. Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression.
Héroult M; Schaffner F; Augustin HG
Exp Cell Res; 2006 Mar; 312(5):642-50. PubMed ID: 16330025
[TBL] [Abstract][Full Text] [Related]
57. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB
Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556
[TBL] [Abstract][Full Text] [Related]
58. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
[TBL] [Abstract][Full Text] [Related]
59. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
[TBL] [Abstract][Full Text] [Related]
60. Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions.
Ieguchi K; Tomita T; Takao T; Omori T; Mishima T; Shimizu I; Tognolini M; Lodola A; Tsunoda T; Kobayashi S; Wada S; Maru Y
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
